biomarker

An alpha-synuclein seed amplification assay (SAA) accurately detected Parkinson's disease in…

<!-- Name:DistributionId Value:8793749 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8789256 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8788771 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

Investigators at the Brigham looked at 1,783 inpatients and outpatients who had cystatin C and creatinine levels drawn within 24 hours from January 1, 2018 until September 9, 2020. They…

"Therapies are lacking, but it's difficult to develop and test new therapies because we don't have a good way to determine the right patients for the therapy," said Virginia Byers Kraus,…

A MedUni Vienna research team has discovered a highly potent biomarker for clinical response to CAR-T cell therapy, describing the prerequisites for optimal use of this novel therapy for…

RVT-3101 demonstrated statistically significant and clinically meaningful efficacy at each dose testedAcross all patients treated with RVT-3101, the clinical remission and endoscopic…

"At present, diagnosing Alzheimer's disease requires neuroimaging," said senior author Thomas Karikari, Ph.D., assistant professor of psychiatry at Pitt. "Those tests are expensive and take…

A group of neuroscientists led by a University of Pittsburgh School of Medicine researcher developed a test to detect a novel marker of Alzheimer's disease neurodegeneration in a blood…